When was StrandAI founded?

StrandAI was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is StrandAI located?

StrandAI is headquartered in San Francisco, United States.

How many employees does StrandAI have?

As of Mar 31, 2026, the latest employee count at StrandAI is 2.

Is StrandAI a funded company?

StrandAI is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 01, 2026.

When was the latest funding round of StrandAI?

StrandAI's latest funding was a $***** Seed round on Jan 01, 2026, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $610M in funding in 2026 to date.

Where does StrandAI rank among its competitors?

StrandAI ranks 106th amongst 194 active competitors, of which 37 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was StrandAI, which secured $500K in Jan, 2026.

Who are the top competitors of StrandAI?

StrandAI's top competitors include Manifold AI, Komodo Health and Apheris. Among them, StrandAI secured the most recent funding round in January, 2026.

StrandAI - 2026 Company Profile, Team, Funding & Competitors

StrandAI is a seed company based in San Francisco (United States), founded in 2025 by Oded Falik and Yue Dai. It operates as a Developer of AI to predict missing patient data modalities. StrandAI has raised $500K in funding. The company has 194 active competitors, including 37 funded and 10 that have exited. Its top competitors include companies like Manifold AI, Komodo Health and Apheris.

Company Details

Developer of AI to predict missing patient data modalities. It offers solutions for predicting biological modalities from existing patient data. The AI helps rescue incomplete cohorts by predicting missing modalities. It also helps skip expensive assays by predicting proteomics or transcriptomics. The AI unlocks rare disease cohorts by filling in missing modalities. It imputes unmeasured markers across entire cohorts.

Website: strandai.com
Email ID: *****@strand.ai

Key Metrics

Founded Year

2025

Location

San Francisco, United States

Stage

Seed

Total Funding

$500K in 1 round

Latest Funding Round

Seed, Jan 01, 2026, $*****

Investors

Y Combinator

Ranked

106^th among 194 active competitors

Employee Count

2 as on Mar 31, 2026

Similar Companies

Manifold AI & 199 more

View StrandAI's full profile

StrandAI has raised a total funding of $500K over 1 round. Its latest funding round was a Seed round on Jan 01, 2026 for $*****. 1 investor participated in its latest round. StrandAI has 1 institutional investor.

Here is the list of recent funding rounds of StrandAI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2026	7096961	Seed	9546297	4548244	6630077	1179728

Access funding benchmarks and valuations. Sign up today!

View details of StrandAI's funding rounds and investors

The founders of StrandAI are Oded Falik and Yue Dai. Yue Dai is the CEO of StrandAI.

Here are the details of StrandAI's key team members:

Oded Falik: Co-Founder & CTO of StrandAI.
Contact Info: 1 email address
Yue Dai: Co-Founder & CEO of StrandAI.
Contact Info: 1 email address

View details of StrandAI's Founder profiles and Board Members

StrandAI's employee count trend

StrandAI has 2 employees as of Mar 26. Here is StrandAI's employee count trend over the years:

Uncover StrandAI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of StrandAI include Manifold AI, Komodo Health and Apheris. Here is the list of Top 10 competitors of StrandAI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	73/100
2nd	Komodo Health 2014, New York City (United States), Series E	AI and cloud-based platforms provide data-driven insights to healthcare providers	$514M	Coatue, Tiger Global Management & 13 others	72/100
3rd	Apheris 2019, Berlin (Germany), Series A	Provider of data analytics solutions for life science industry	$32.5M	LocalGlobe, OTB Ventures & 16 others	61/100
4th	HitGen 2012, Lanzhou (China), Public	Developer of DNA encoded libraries for drug discovery	$39.1M	CDH, Shiyu & 2 others	57/100
5th	Slingshot Bioscience 2012, Berkeley (United States), Series A	Developer of next-generation synthetic cells for diagnostics and therapeutics	$46.4M	Northpond Ventures, Arch Venture Partners ... & 2 others	56/100
6th	Qureight 2018, Cambridge (United Kingdom), Series A	AI enabled data curation platform for drug development	$11.2M	Playfair Capital, CMS Ventures & 18 others	55/100
7th	Seven Bridges Genomics 2009, Cambridge (United States), Acquired	Biomedical data analysis company accelerating healthcare research with software and analytics	$113M	First Star Ventures, Western Technology Investment ... & 3 others	54/100
8th	Reliant AI 2023, Montreal (Canada), Seed	Provider of an AI platform for biopharmaceutical research and development	$13.5M	Inovia Capital, Tola Capital & 5 others	54/100
9th	Medeloop 2021, San Francisco (United States), Series A	CRO focused on drugs discovery services	$23.5M	Inovia Capital, General Catalyst & 8 others	54/100
10th	InterAx Biotech 2016, Villigen (Switzerland), Series A	Arrestin-based biosensors and computational methods for GPCR based drug discovery	$3.19M	Verve Ventures, Venture Kick & 5 others	53/100
106th	StrandAI 2025, San Francisco (United States), Seed	Developer of AI to predict missing patient data modalities	$500K	Y Combinator	23/100